Breaking News

Polyplus launches transgene plasmid engineering services for viral vector manufacturing

The upstream solutions provider for advanced biologic and cell and gene therapy production

Linneo Health expands medicinal offering to include industrial cannabis derivatives

Linneo Health to expand offering of medicinal cannabis products to include APIs and cannabis extracts, under the terms of a CDMO agreement with Alc...

Olon and Milan Uni create photochemistry process scholarship for APIs

Olon and the University of Milan's Department of Chemistry announce the creation of a Scholarship for a PhD in the development of new photochemistr...

Staying ahead of the ADC curve

Even after the first antibody–drug conjugate (ADC) was approved in 2000 — Pfizer’s Mylotarg (gemtuzumab ozogamacin) — it took some time for these p...

Have you got screen fatigue?

Read Manufacturing Chemist in print, at your leisure

Polpharma Biologics announces FDA file acceptance for review of natalizumab

Polpharma Biologics announces that the US Food and Drug Administration (FDA) has accepted the first-ever Biologics License Application (BLA) for na...

A risk mitigation approach to detecting and quantifying metals in APIs

If trace quantities of metals are present in active pharmaceutical ingredients (APIs) or final drug products, they have the potential to adversely...

Manufacturing Chemist LIVE 2022 in review (part I)

Taking a front row seat during the two-day pharmaceutical conference in Birmingham, UK, Dr Kevin Robinson reports on what’s new, emerging and excit...

DOMO Chemicals announces stronger sustainability targets for people and the planet

DOMO Chemicals has announced ambitious new sustainability targets, accelerating the group’s strategy to be recognised as an industry leader in sust...

DFE Pharma expands its inhalation portfolio with the launch of Lactohale 400

Being a leader in dry powder inhalation, DFE Pharma further expands its broad excipient portfolio of inhalation grade lactose

CBD: the new frontier in medical science

Early stage drug development plays an important role in expanding treatment options that will support the health of patients globally. To create be...

Harnessing the power of HPAPIs: key considerations

Adam Kujath, Senior Director at Sterling Pharma Solutions, discusses the key issues that companies need to consider when embarking on an HPAPI proj...

Merck opens $63m CDMO facility to handle HPAPIs

The industry expert has announced that its Life Science business sector has doubled its highly potent active pharmaceutical ingredients (HPAPI) pro...

Innovative new process used to produce a diabetes and weight loss drug

Camilla Koller, Marketing Communications Associate, tells Dr Kevin Robinson how Bachem has used its extensive experience and expertise in peptide s...

Ixaka and Minaris sign tech transfer and GMP manufacturing agreement

The two companies have signed the agreement for Ixaka lead autologous multi-cell therapy

Developments in global pharmaceutical excipients in the next 3–5 years: part II

Key themes that will shape the excipient landscape in the near future will include regulations, innovation, economics and sustainability, says Dr I...